View in EDS HTML Full Text PDF Full Text

Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum.

Saved in:
Bibliographic Details
Title: Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum.
Authors: Salvia, Giorgia1 (AUTHOR) giorgia.salvia2@gmail.com, Bevilacqua, Matteo1 (AUTHOR), Manzo Margiotta, Flavia1,2 (AUTHOR), Michelucci, Alessandra1,2 (AUTHOR), Granieri, Giammarco1 (AUTHOR), Fidanzi, Cristian1 (AUTHOR), Dini, Valentina1 (AUTHOR), Romanelli, Marco1 (AUTHOR), Mazzatenta, Carlo3 (AUTHOR)
Source: Australasian Journal of Dermatology. Jun2024, Vol. 65 Issue 4, pe111-e113. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00048380
DOI:10.1111/ajd.14266